Neurological & Psychological Disorders
News on research and diagnostic developments in neuroscience.
Linus Biotechnology Raises $16M in Series A Funding
The Mount Sinai spinout will use the funds to advance its StrandDx platform, correlating environmental exposures to biological responses.
Roche Alzheimer's Disease Assays Obtain FDA 510(k) Clearance
The two cerebrospinal fluid-based Elecsys tests will be available on Roche's Cobas immunoassay analyzers.
Japanese Consortium Launches Study to Evaluate Utility of Blood-Based Alzheimer's Markers
Shimadzu, Eisai, Oita University, and Usuki City Medical Association are studying the markers in 100 patients using Shimadzu's mass spec technology.
Drug, Diagnostic Developer HMNC Brain Health Raises €14.3M
The German company is developing drugs and companion diagnostics for a range of psychiatric conditions including major depressive disorder.
Genetika+ Snags CE Mark for Major Depressive Disorder Drug-Matching Test
The NeuroKaire test predicts a patient's drug response by combining patient-reported information, pharmacogenetics data, and so-called "brain-in-a-dish" functional testing.